The Financial Burden of Functional Neurological Disorders
Authors:
- 11 September 2023
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 23 (10) , 637-643
Abstract
Purpose of Review Functional neurological disorder (FND) is a common and severely debilitating condition lacking clinical ownership, existing between neurology and psychiatry. This article reports the findings of recent research investigating the economic costs of FND diagnosis and management. We define what the costs are, why they exist, and suggest actionable steps to reduce them. Recent Findings The financial burden of FND exists across the globe characterized by high healthcare utilization resulting in exorbitant direct and indirect costs for the patient, healthcare system, and society. Inadequate medical education and stigmatization of the disorder prolong the time to diagnosis, during which cyclical utilization of inpatient and emergency department services drive up costs. Despite being cost-effective, lack of accessible treatment compounds the issue, leaving patients without a reliable exit. Summary Recent findings support an increased awareness and the need for a cultural shift to overcome the financial burden associated with this underserved population.Keywords
This publication has 43 references indexed in Scilit:
- Adult-onset psychogenic nonepileptic seizures: A multicenter international studyEpilepsy & Behavior, 2019
- Welfare consequences for people diagnosed with nonepileptic seizures: A matched nationwide study in DenmarkEpilepsy & Behavior, 2019
- Survey of the perceptions of health practitioners regarding Functional Neurological Disorders in AustraliaJournal of Clinical Neuroscience, 2019
- Del trastorno conversivo a los trastornos neurológicos funcionales. ¿Superando el diagnóstico por descarte?Revista Colombiana de Psiquiatría, 2019
- Psychological long‐term outcome in patients with psychogenic nonepileptic seizuresEpilepsia, 2019
- Medical health care utilization cost of patients presenting with psychogenic nonepileptic seizuresEpilepsia, 2018
- Diagnostic delay in psychogenic seizures and the association with anti-seizure medication trialsSeizure: European Journal of Epilepsy, 2016
- Epidemiology2016
- Autonomy and the “demanding encounter” in clinical neurologyNeurology Clinical Practice, 2015
- Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society membersMovement Disorders, 2009